Multicenter study of the efficacy and safety of fexofenadine 60 mg. twice daily in 108 Thai patients with chronic idiopathic urticaria.
Kanokvalai Kulthanan(Siriraj Hospital), Prisana Kullavanijaya, Wiwat Korkij(Chulalongkorn University), Chasuree Sitakalin, Monnate Kuntiranont, Kobkul Aunhachoke(Phramongkutklao Hospital), Nanthachak Gherunpong, Sukhum Jiamton(Siriraj Hospital), Pimonpun Gritiyarangsan, Somyot Charuwichitratana(Mahidol University), Janthom Krisadapong, Patcharin Janjumratsang
PubMed
February 1, 2001
Cited by 9
Related Papers
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.5k
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k
Urticaria
|Nature Reviews Disease Primers|2022|368
The global burden of chronic urticaria for the patient and society*
|British Journal of Dermatology|2020|351
Chronic idiopathic urticaria: prevalence and clinical course
|The Journal of Dermatology|2007|184